Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$13.42 - $23.53 $4,012 - $7,035
-299 Reduced 0.85%
34,775 $741,000
Q4 2023

Feb 13, 2024

SELL
$7.58 - $14.38 $1,076 - $2,041
-142 Reduced 0.4%
35,074 $504,000
Q3 2023

Nov 13, 2023

BUY
$8.44 - $11.86 $32,468 - $45,625
3,847 Added 12.26%
35,216 $321,000
Q2 2023

Aug 04, 2023

SELL
$9.62 - $13.99 $19 - $27
-2 Reduced 0.01%
31,369 $331,000
Q1 2023

May 12, 2023

BUY
$10.71 - $14.6 $6,693 - $9,125
625 Added 2.03%
31,371 $383,000
Q4 2022

Feb 10, 2023

BUY
$11.23 - $16.9 $7,007 - $10,545
624 Added 2.07%
30,746 $381,000
Q3 2022

Nov 14, 2022

BUY
$12.01 - $19.45 $5,104 - $8,266
425 Added 1.43%
30,122 $411,000
Q2 2022

Aug 12, 2022

SELL
$10.71 - $18.33 $19,824 - $33,928
-1,851 Reduced 5.87%
29,697 $544,000
Q1 2022

May 13, 2022

SELL
$11.78 - $16.98 $26,163 - $37,712
-2,221 Reduced 6.58%
31,548 $507,000
Q4 2021

Feb 11, 2022

SELL
$12.22 - $19.57 $12,342 - $19,765
-1,010 Reduced 2.9%
33,769 $473,000
Q3 2021

Nov 12, 2021

SELL
$15.42 - $21.72 $12,752 - $17,962
-827 Reduced 2.32%
34,779 $651,000
Q2 2021

Aug 13, 2021

SELL
$20.85 - $29.88 $18,264 - $26,174
-876 Reduced 2.4%
35,606 $742,000
Q1 2021

May 07, 2021

BUY
$24.75 - $39.14 $17,894 - $28,298
723 Added 2.02%
36,482 $1.03 Million
Q4 2020

Feb 12, 2021

BUY
$29.0 - $41.62 $117,131 - $168,103
4,039 Added 12.73%
35,759 $1.17 Million
Q3 2020

Nov 04, 2020

SELL
$16.3 - $30.64 $11,752 - $22,091
-721 Reduced 2.22%
31,720 $972,000
Q2 2020

Aug 12, 2020

BUY
$7.95 - $18.81 $96,401 - $228,090
12,126 Added 59.69%
32,441 $529,000
Q1 2020

May 04, 2020

SELL
$6.45 - $14.04 $7,572 - $16,482
-1,174 Reduced 5.46%
20,315 $202,000
Q4 2019

Feb 05, 2020

SELL
$12.97 - $15.94 $2,347 - $2,885
-181 Reduced 0.84%
21,489 $295,000
Q3 2019

Nov 08, 2019

BUY
$14.75 - $20.87 $47,819 - $67,660
3,242 Added 17.59%
21,670 $329,000
Q2 2019

Aug 13, 2019

BUY
$14.71 - $19.79 $5,678 - $7,638
386 Added 2.14%
18,428 $363,000
Q1 2019

May 06, 2019

SELL
$13.73 - $16.87 $8,018 - $9,852
-584 Reduced 3.14%
18,042 $299,000
Q4 2018

Feb 13, 2019

SELL
$10.6 - $17.49 $1,547 - $2,553
-146 Reduced 0.78%
18,626 $262,000
Q3 2018

Nov 09, 2018

BUY
$16.65 - $21.85 $43,006 - $56,438
2,583 Added 15.96%
18,772 $329,000
Q2 2018

Aug 08, 2018

BUY
$14.8 - $18.8 $36,038 - $45,778
2,435 Added 17.7%
16,189 $295,000
Q1 2018

May 07, 2018

BUY
$14.5 - $23.4 $2,610 - $4,212
180 Added 1.33%
13,754 $258,000
Q4 2017

Feb 09, 2018

BUY
$13.5 - $16.65 $54,162 - $66,799
4,012 Added 41.96%
13,574 $208,000
Q3 2017

Nov 09, 2017

BUY
$6.05 - $14.95 $57,850 - $142,951
9,562
9,562 $143,000

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $598M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.